IQVIA's Investor Day Next Catalyst Following Q3 Beat, RBC Says

MT Newswires Live00:41

IQVIA (IQV) beat Q3 expectations and raised guidance, with its investor day set to be the next catalyst, RBC Capital Markets said in a note Tuesday.

Key macroeconomic indicators are showing high-single-digit growth, while the company continues to benefit from its differentiated data analytics capabilities, including artificial intelligence, the analysts said.

The analysts added they expect AI to remain a net tailwind for IQVIA as biopharmaceutical companies seek outsourced research and development capacity, speed, and improved success rates.

The next key catalyst is IQVIA's investor day on Dec. 1, when the company is expected to outline its 2027 growth framework, provide a long-range plan, and discuss how AI and data analytics could support growth, the analysts said, adding that more detailed 2027 guidance is expected with the company's Q4 earnings report.

RBC kept its outperform rating and $319 price target on IQVIA.

Price: 276.51, Change: +4.96, Percent Change: +1.83

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2679949794?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-29 00:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2679949794","market":"sg","top_or_hot":-1,"title":"IQVIA's Investor Day Next Catalyst Following Q3 Beat, RBC Says","media":"MT Newswires Live","content":"<html><body><p> IQVIA (IQV) beat Q3 expectations and raised guidance, with its investor day set to be the next catalyst, RBC Capital Markets said in a note Tuesday.</p><p>Key macroeconomic indicators are showing high-single-digit growth, while the company continues to benefit from its differentiated data analytics capabilities, including artificial intelligence, the analysts said.</p><p>The analysts added they expect AI to remain a net tailwind for IQVIA as biopharmaceutical companies seek outsourced research and development capacity, speed, and improved success rates.</p><p>The next key catalyst is IQVIA's investor day on Dec. 1, when the company is expected to outline its 2027 growth framework, provide a long-range plan, and discuss how AI and data analytics could support growth, the analysts said, adding that more detailed 2027 guidance is expected with the company's Q4 earnings report.</p><p>RBC kept its outperform rating and $319 price target on IQVIA.</p><p>Price: 276.51, Change: +4.96, Percent Change: +1.83</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IQVIA's Investor Day Next Catalyst Following Q3 Beat, RBC Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIQVIA's Investor Day Next Catalyst Following Q3 Beat, RBC Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-10-29 00:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> IQVIA (IQV) beat Q3 expectations and raised guidance, with its investor day set to be the next catalyst, RBC Capital Markets said in a note Tuesday.</p><p>Key macroeconomic indicators are showing high-single-digit growth, while the company continues to benefit from its differentiated data analytics capabilities, including artificial intelligence, the analysts said.</p><p>The analysts added they expect AI to remain a net tailwind for IQVIA as biopharmaceutical companies seek outsourced research and development capacity, speed, and improved success rates.</p><p>The next key catalyst is IQVIA's investor day on Dec. 1, when the company is expected to outline its 2027 growth framework, provide a long-range plan, and discuss how AI and data analytics could support growth, the analysts said, adding that more detailed 2027 guidance is expected with the company's Q4 earnings report.</p><p>RBC kept its outperform rating and $319 price target on IQVIA.</p><p>Price: 276.51, Change: +4.96, Percent Change: +1.83</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0648000940.SGD","symbol_name":"Natixis Harris Associates Global Equity RA SGD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2679949794","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2679949794","pubTimestamp":1793205663,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"IQVIA  beat Q3 expectations and raised guidance, with its investor day set to be the next catalyst, RBC Capital Markets said in a note Tuesday.Key macroeconomic indicators are showing high-single-digit growth, while the company continues to benefit from its differentiated data analytics capabilities, including artificial intelligence, the analysts said.The analysts added they expect AI to remain a net tailwind for IQVIA as biopharmaceutical companies seek outsourced research and development capacity, speed, and improved success rates.The next key catalyst is IQVIA's investor day on Dec. 1, when the company is expected to outline its 2027 growth framework, provide a long-range plan, and discuss how AI and data analytics could support growth, the analysts said, adding that more detailed 2027 guidance is expected with the company's Q4 earnings report.RBC kept its outperform rating and $319 price target on IQVIA.Price: 276.51, Change: +4.96, Percent Change: +1.83","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","LU0882574055.USD":"富达全球健康医疗A ACC","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","LU1261432733.SGD":"Fidelity World A-ACC-SGD","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","LU0130518102.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"R\" INC","BK4530":"医药外包概念","LU0477156797.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"RE\" (USD) ACC","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC","BK4588":"碎股","HEAL":"Global X HealthTech ETF","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","EKG":"First Trust Nasdaq Lux Digital Health Solutions ETF","LU0528227936.USD":"富达环球人口趋势基金A-ACC","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","BK4585":"ETF&股票定投概念","BK4121":"生命科学工具和服务","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","IQV":"艾昆纬"},"translate_title":"加拿大皇家银行表示，IQVIA 的投资者日是继第三季度业绩之后的下一个催化剂","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HEAL":0.6,"IQV":1.5,"EKG":0.6},"content_text":"IQVIA (IQV) beat Q3 expectations and raised guidance, with its investor day set to be the next catalyst, RBC Capital Markets said in a note Tuesday.Key macroeconomic indicators are showing high-single-digit growth, while the company continues to benefit from its differentiated data analytics capabilities, including artificial intelligence, the analysts said.The analysts added they expect AI to remain a net tailwind for IQVIA as biopharmaceutical companies seek outsourced research and development capacity, speed, and improved success rates.The next key catalyst is IQVIA's investor day on Dec. 1, when the company is expected to outline its 2027 growth framework, provide a long-range plan, and discuss how AI and data analytics could support growth, the analysts said, adding that more detailed 2027 guidance is expected with the company's Q4 earnings report.RBC kept its outperform rating and $319 price target on IQVIA.Price: 276.51, Change: +4.96, Percent Change: +1.83","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2679949794","isCrawlerRequest":true}